IM Cannabis Corp. Files February 2025 6-K Report

Ticker: IMCC · Form: 6-K · Filed: 2025-03-05T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, 6-k, reporting

TL;DR

IM Cannabis Corp. filed its monthly 6-K, no major news, just routine reporting.

AI Summary

IM Cannabis Corp. filed a Form 6-K on March 5, 2025, reporting for the month of February 2025. The filing indicates the company is a foreign private issuer and will file annual reports under Form 20-F. No specific financial transactions or operational updates were detailed in this particular filing.

Why It Matters

This filing serves as a routine update for investors, confirming the company's status as a foreign private issuer and its reporting schedule. It does not contain new financial or operational information.

Risk Assessment

Risk Level: low — This is a routine filing with no new material information, financial updates, or operational changes disclosed.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of February 2025.

What is the filing date of this report?

The filing date is March 5, 2025.

Does IM Cannabis Corp. file annual reports under Form 20-F or 40-F?

IM Cannabis Corp. indicates it files annual reports under Form 20-F.

What is the principal executive office address for IM Cannabis Corp.?

The principal executive offices are located at Kibbutz Glil Yam, Central District, Israel, 4690500.

Does this filing contain specific financial results or operational updates for February 2025?

No, this filing is a routine report for the month of February 2025 and does not detail specific financial results or operational updates.

From the Filing

0001178913-25-000692.txt : 20250305 0001178913-25-000692.hdr.sgml : 20250305 20250305070332 ACCESSION NUMBER: 0001178913-25-000692 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250305 FILED AS OF DATE: 20250305 DATE AS OF CHANGE: 20250305 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 25708796 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2532801.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of February 2025 .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒  Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____   Note : Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____   Note : Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.   SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.       IM CANNABIS CORP.     (Registrant)         Date: March 5, 2025 By: /s/ Oren Shuster     Name: Oren Shuster     Title: Chief Executive Officer and Director   EXHIBIT INDEX   99.1 Form 7 - Monthly Progress Report dated March 5, 2025 EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 FORM 7 MONTHLY PROGRESS REPORT   Name of Listed Issuer: IM Cannabis Corp. (the “ Issuer ” or “ IMC ” or the " Company ")   Trading Symbol: IMCC   Number of Outstanding Listed Securities as of 02/28/2025: 3,085,452 Common Shares   Date: March 5, 2025   Report on Business   1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was inactive disclose this fact.   • "Anti-Dumping” investigation into cannabis imports from Canada On January 26, 2025, the Jerusalem District Court held a hearing on the administrative petition filed by the local growers seeking to impose a temporary guara

View on Read The Filing